Metabolic Enzyme-Targeting Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
94
NCT05055609
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 23, 2021
Completion: Jun 1, 2027
Loading map...